EverPoint Asset Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

EverPoint Asset Management’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$12.6M	Sell	985,050 -1,283,550	-57%	-$16.2M	0.23%	118
2016 Q3	$30.2M	Sell	2,268,600 -716,400	-24%	-$8.38M	0.54%	42
2016 Q2	$32.7M	Sell	2,985,000 -250,740	-8%	-$2.45M	0.64%	35
2016 Q1	$29.6M	Buy	3,235,740 +429,840	+15%	+$3.55M	0.58%	28
2015 Q4	$27.2M	Buy	2,805,900 +537,300	+24%	+$5.19M	0.57%	35
2015 Q3	$19.8M	Buy	2,268,600 +537,300	+31%	+$5.01M	0.51%	45
2015 Q2	$17.5M	Buy	1,731,300 +1,014,900	+142%	+$11.8M	0.32%	86
2015 Q1	$9.6M	Buy	716,400 +119,400	+20%	+$1.57M	0.18%	178
2014 Q4	$7.66M	Buy	597,000 +388,050	+186%	+$4.44M	0.17%	189
2014 Q3	$2.27M	Buy	208,950 +11,940	+6%	+$137K	0.05%	343
2014 Q2	$2.53M	Buy	+197,010	New	+$2.14M	0.05%	382

Other funds holding IRWD

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

EverPoint Asset Management's IRWD Position: Q4 2016 in Review

EverPoint Asset Management reduced its Ironwood Pharmaceuticals (IRWD) stake by 57% in Q4 2016, selling an estimated $16.2M and leaving 985,050 shares worth $12.6M. The position accounts for 0.23% of the portfolio, ranked #118.

EverPoint Asset Management first reported a position in IRWD in Q2 2014 and has held it in 11 quarters since. The position peaked at $32.7M in Q2 2016. 163 funds tracked by Wall St. Rank hold IRWD as of Q4 2016.

EverPoint Asset Management held 985,050 shares of Ironwood Pharmaceuticals worth $12.6M as of Q4 2016.
EverPoint Asset Management sold 1,283,550 Ironwood Pharmaceuticals shares in Q4 2016, an estimated $16.2M.
Ironwood Pharmaceuticals made up 0.23% of EverPoint Asset Management's portfolio in Q4 2016, its #118 holding.
EverPoint Asset Management first reported a position in Ironwood Pharmaceuticals in Q2 2014 and has held it in 11 quarters since.
EverPoint Asset Management's Ironwood Pharmaceuticals position peaked at $32.7M in Q2 2016.
163 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q4 2016.

Based on EverPoint Asset Management's 13F filing for Q4 2016, filed 14 Feb 2017.